Abstract
Neuroblastoma is a rare sympathetic nervous system neoplasia with a broad spectrum of clinical presentations. Prognosis depends on age, stage, genetic and histological features. However, in spite of favorable prognostic factors, the event-free survival of some neuroblastoma patients with localized disease may be poor. Since the Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), involved in nervous system development and neuritis extension, has been linked to tumor progression and metastasis in several tumor types, we studied its expression in neuroblastoma cell lines and primary tumors from patients with localized neuroblastoma. Neuroblastoma cell lines display various levels of ALCAM surface expression, which can be dynamically regulated by metalloprotease-mediated shedding. More importantly, ALCAM is expressed also in neuroblastoma primary tumors and diverse patterns of subcellular localization can be observed. In patients with localized disease and favorable prognostic factors, high levels of ALCAM membrane expression, together with low expression in the cytoplasm and neuropil area, were significantly associated with relapse, suggesting that high ALCAM membrane expression may represent a new negative prognostic factor in these patients. In conclusion, assessment of ALCAM subcellular localization may represent a useful tool to identify patients at high risk of relapse that could benefit from a more careful follow-up.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Buhusi M, Demyanenko GP, Jannie KM, Dalal J, Darnell EP, Weiner JA, Maness PF (2009) ALCAM regulates mediolateral retinotopic mapping in the superior colliculus. J Neurosci 29:15630–15641
Burkhardt M, Mayordomo E, Winzer KJ, Fritzsche F, Gansukh T, Pahl S, Weichert W, Denkert C, Guski H, Dietel M, Kristiansen G (2006) Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59:403–409
Clagett-Dame M, McNeill EM, Muley PD (2006) Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J Neurobiol 66:739–756
Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK, INRG Task Force (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27:289–297
Corrias MV, Gambini C, Gregorio A, Croce M, Barisione G, Cossu C, Rossello A, Ferrini S, Fabbi M (2010) Different subcellular localization of ALCAM molecules in neuroblastoma: association with relapse. Cell Oncol 32:77–86
Jezierska A, Olszewski WP, Pietruszkiewicz J, Olszewski W, Matysiak W, Motyl T (2006) Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion. Med Sci Monit 12:BR245–BR256
Kijima N, Hosen N, Kagawa N, Hashimoto N, Nakano A, Fujimoto Y, Kinoshita M, Sugiyama H, Yoshimine T (2011) CD166/Activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. Neuro Oncol 14(3):1–11
Maris JM (2010) Recent advances in neuroblastoma. N Engl J Med 362:2202–2211
Mezzanzanica D, Fabbi M, Bagnoli M, Staurengo S, Losa M, Balladore E, Alberti P, Lusa L, Ditto A, Ferrini S, Pierotti MA, Barbareschi M, Pilotti S, Canevari S (2008) Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients. Clin Cancer Res 14:1726–1733
Navarro S, Amann G, Beiske K, Cullinane CJ, d’Amore ES, Gambini C, Mosseri V, De Bernardi B, Michon J, Peuchmaur M (2006) Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 trial and protocol. J Clin Oncol 24:695–699
Ofori-Acquah SF, King JA (2008) Activated leukocyte cell adhesion molecule: a new paradox in cancer. Transl Res 151:122–128
Ott H, Diekmann H, Stuermer CA, Bastmeyer M (2001) Function of Neurolin (DM-GRASP/SC-1) in guidance of motor axons during zebrafish development. Dev Biol 235:86–97
Piazza T, Cha E, Bongarzone I, Canevari S, Bolognesi A, Polito L, Bargellesi A, Sassi F, Ferrini S, Fabbi M (2005) Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. J Cell Sci 118:1515–1525
Rosso O, Piazza T, Bongarzone I, Rossello A, Mezzanzanica D, Canevari S, Orengo AM, Puppo A, Ferrini S, Fabbi M (2007) The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Mol Cancer Res 5:1246–1253
Swart GW (2002) Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur J Cell Biol 81:313–321
Tachezy M, Zander H, Marx AH, Gebauer F, Rawnaq T, Kaifi JT, Sauter G, Izbicki JR, Bockhorn M (2011) ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients. J Surg Res 170:226–232
van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW (2000) Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 156:769–774
Wade A, Thomas C, Kalmar B, Terenzio M, Garin J, Greensmith L, Schiavo G (2012) Activated leukocyte cell adhesion molecule (alcam) modulates neurotrophin signaling. J Neurochem 120(1):7–25
Weichert W, Knosel T, Bellach J, Dietel M, Kristiansen G (2004) ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57:1160–1164
Weiner JA, Koo SJ, Nicolas S, Fraboulet S, Pfaff SL, Pourquie O, Sanes JR (2004) Axon fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin superfamily adhesion molecule BEN/ALCAM/SC1. Mol Cell Neurosci 27:59–69
Wierzbicki A, Gil M, Ciesielski M, Fenstermaker RA, Kaneko Y, Rokita H, Lau JT, Kozbor D (2008) Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells. J Immunol 181:6644–6653
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Corrias, M.V., Croce, M., Fabbi, M. (2013). Neuroblastoma: Role of Activated Leukocyte Cell Adhesion Molecule. In: Hayat, M. (eds) Pediatric Cancer, Volume 4. Pediatric Cancer, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6591-7_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-6591-7_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6590-0
Online ISBN: 978-94-007-6591-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)